Mirtazapine augmentation enhances cognitive and negative symptoms in schizophrenic patients treated with risperidone: a controlled study
This study is recruiting in South Korea. It focuses on Schizophrenia.
In South Korea
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in South Korea. It focuses on Schizophrenia.
In South KoreaThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Switzerland and the United States.
Multiple locations, including New HavenThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Taiwan.
In TaichungThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ShanghaiThis study is recruiting in Germany. It is testing neurotransmitters and neuropeptides for schizophrenia.
In GermanyThis study is recruiting. It focuses on bipolarity and currently lists participation information in Canada.
In HamiltonThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Portugal.
In Vila RealThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In San DiegoThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United Kingdom